PD
PTCT icon

Point72 (DIFC)’s PTC Therapeutics PTCT Stock Holding History

Point72 (DIFC)’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-835
Closed -$37.7K – 1992
2024
Q4 		$37.7K Buy
+835
New +$35.7K ﹤0.01% 1172
2024
Q3 		– Sell
-4,437
Closed -$136K – 1746
2024
Q2 		$136K Sell
4,437
-55
-1% -$1.78K ﹤0.01% 919
2024
Q1 		$131K Buy
+4,492
New +$126K ﹤0.01% 1049

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s PTCT Position: Q1 2025 in Review

Point72 (DIFC) sold out of PTC Therapeutics (PTCT) in Q1 2025, closing a stake of 835 shares — an estimated $37.7K sold.

Point72 (DIFC) first reported a position in PTCT in Q1 2024 and held it in 3 quarters. The position peaked at $136K in Q2 2024. 260 funds tracked by Wall St. Rank hold PTCT as of Q1 2025.

  • Point72 (DIFC) reported no remaining PTC Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 835 PTC Therapeutics shares in Q1 2025, an estimated $37.7K.
  • Point72 (DIFC) first reported a position in PTC Therapeutics in Q1 2024 and held it in 3 quarters.
  • Point72 (DIFC)'s PTC Therapeutics position peaked at $136K in Q2 2024.
  • 260 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.